Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Confirmatory Trial of Multidisciplinary Digital Therapeutics for Patellofemoral Pain Syndrome
Sponsor: EverEx Inc.
Summary
This randomized controlled confirmatory study will be evaluating an mobile application, MORA Cure (ETH-01K), owned by EverEx, Inc., to examine safety and effectiveness in individuals with patellofemoral pain syndrome.
Official title: Prospective, Randomized, Controlled Confirmatory Clinical Investigation to Evaluate the Safety and Efficacy of a Multidisciplinary Digital Therapeutics in Patients with Patellofemoral Pain Syndrome
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
216
Start Date
2024-04-26
Completion Date
2025-03-31
Last Updated
2025-01-23
Healthy Volunteers
No
Conditions
Interventions
MORA Cure
MORA Cure (ETH-01K), developed by EverEx, Inc., is a digital therapeutics (S/W medical device) designed to provide multidisciplinary rehabilitation treatment, a combination of graded exercise therapy and cognitive behavioural therapy for patients with patellofemoral pain syndrome.
Treatment as Usual
In the control group, education is delivered and self-exercise is recommended.
Locations (10)
Myongji Hospital
Goyang-si, Gyeonggi-do, South Korea
Hanyang University Guri Hospital
Guri-si, Gyeonggi-do, South Korea
Seoul National University Bundang Hospital
Gyeonggi-do, Gyeonggi-do, South Korea
CHA Bundang Medical Center
Seongnam-si, Gyeonggi-do, South Korea
Inha University Hospital
Junggu, Incheon, South Korea
Chung-Ang University Hospital
Dongjak, Seoul, South Korea
Seoul Metropolitan Government-Seoul National University Boramae Medical Center
Dongjak, Seoul, South Korea
Kyung Hee University Hospital at Gangdong
Gangdong, Seoul, South Korea
The Catholic University of Korea Seoul St. Mary's Hospital
Seocho, Seoul, South Korea
Asan Medical Center
Seoul, Seoul, South Korea